Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (2,550,879)	$ (2,774,312)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash stock compensation issued for services	149,900	66,850
Non-cash stock compensation issued to directors and employees	46,503	243,362
Fair value of stock options issued to employees	325,834	428,488
Non-cash compensation for services	45,000
Amortization of discount on notes payable	178,380
Amortization of leasehold right of use asset	57,859	56,899
Loss from equity method investment	27,735	71,117
Depreciation and amortization	19,087	15,547
Changes in assets and liabilities:
Accounts receivable	(22,571)	(8,250)
Inventory	(7,317)	(6,858)
Prepaid expenses and other current assets	(60,677)	54,573
Accounts payable and accrued expenses	498,169	18,789
Accrued compensation	274,420	(189,812)
Deferred revenue	(73,130)	(107)
Leasehold liability	(56,774)	(54,405)
Net cash used in operating activities	(1,148,461)	(2,078,119)
Cash from investing activities:
Payments to acquire property, plant, and equipment		(5,654)
Payments to acquire intangible assets		(910)
Investment in joint ventures	(8,447)	(75,326)
Net cash used in investing activities	(8,447)	(81,890)
Cash from financing activities:
Proceeds from the sale of notes payable	714,000
Proceeds from the sale of common stock, net of offering costs	2,708,642	315,000
Proceeds from option exercise	2,376
Principal payments on note payable	(170,000)
Net cash provided by financing activities	3,255,018	315,000
Increase (decrease) in cash and cash equivalents	2,098,110	(1,845,009)
Cash and cash equivalents at beginning of period	90,135	5,684,871
Cash and cash equivalents at end of period	2,188,245	3,839,862
Supplemental disclosure of cash flow information:
Interest
Taxes
Noncash activities:
Fair value of warrants issued with debt	$ 327,389